Insider trades
P. Kent Hawryluk, CEO of MBX Biosciences MBX, has filed 3 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $780.5K. The latest trade was on 05/06.
P. Kent Hawryluk
President & CEO
- Company
- MBX Biosciences MBX
- First filing
- 24/09/13
- Trades
- 19 trades
- Buys / sales
- 3 / 1
- 12-month net buying
- $780.5K
- Last trade
- 05/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/06 | 05/08 | 607 sh | $29.54 | $17,930.78 | −0.1% | |
| Open-market buy | 03/13 | 03/16 | 18,500 sh | $28.41 | $525,585 | +4.0% | |
| Open-market buy | 25/10/20 | 25/10/21 | 20,000 sh | $13.64 | $272,800 | +4.5% | |
| Open-market buy | 25/02/04 | 25/02/05 | 50,000 sh | $10.69 | $534,500 | +12.6% |